Skip to main content
Fig. 4 | World Journal of Surgical Oncology

Fig. 4

From: Clinical benefits of PD-1/PD-L1 inhibitors in patients with metastatic colorectal cancer: a systematic review and meta-analysis

Fig. 4

The forest figure of response rate (CR, PR, SD, PD) on MMR-MSI subgroup analysis. A CR rate on MMR-MSI subgroup analysis. B PR rate on MMR-MSI subgroup analysis. C SD rate on MMR-MSI subgroup analysis. D PD rate on MMR-MSI subgroup analysis. Complete response rate (CR), partial response rate (PR), stable disease rate (SD), progression disease rate (PD)

Back to article page